Attendo AB/Skr ATT
1D1W1MYTD1Y5YMAX
Capital at risk
About Attendo AB
Attendo AB is a healthcare service provider in the Nordic region, focusing on offering care for older individuals, people with disabilities, and providing social psychiatry services. The company operates through its two main segments: Nursing Homes and Home Care, delivering personalized care solutions. Established in 1985 and headquartered in Danderyd, Sweden, Attendo has expanded its operations across Sweden, Finland, and Denmark. The firm emphasizes quality care and innovative solutions in service delivery, utilizing a decentralized model to adapt to local conditions efficiently. Attendo's strategic approach includes strong regional presence and local community engagement, positioning it as a significant player in the Nordic healthcare sector.
- Ticker
- Skr ATT
- Sector
- Health
- Primary listing
- XSTO
- Employees
- 33,000
- Headquarters
- Danderyd, Sweden
- Website
- www.attendo.com
Attendo AB Metrics
BasicAdvanced
kr 17B
18.53
kr 6.65
1.01
kr 0.90
0.73%
Price and volume
Market cap
kr 17B
Beta
1.01
52-week high
kr 127.20
52-week low
kr 66.70
Average daily volume
347K
Dividend rate
kr 0.90
Financial strength
Current ratio
0.791
Quick ratio
0.661
Long term debt to equity
2.835
Total debt to equity
3.154
Dividend payout ratio (TTM)
13.22%
Interest coverage (TTM)
2.52%
Profitability
EBITDA (TTM)
1,423.4
Gross margin (TTM)
36.90%
Net profit margin (TTM)
5.14%
Operating margin (TTM)
10.34%
Effective tax rate (TTM)
20.65%
Revenue per employee (TTM)
kr 570,000
Management effectiveness
Return on assets (TTM)
4.86%
Return on equity (TTM)
18.72%
Valuation
Price to earnings (TTM)
18.533
Price to revenue (TTM)
0.949
Price to book
3.3
Price to tangible book (TTM)
-5.1
Price to free cash flow (TTM)
6.673
Free cash flow yield (TTM)
14.99%
Free cash flow per share (TTM)
18.462
Dividend yield (TTM)
0.73%
Growth
Revenue change (TTM)
-1.07%
Earnings per share change (TTM)
81.08%
3-year revenue growth (CAGR)
6.19%
10-year revenue growth (CAGR)
6.60%
3-year earnings per share growth (CAGR)
97.73%
10-year earnings per share growth (CAGR)
9.10%
10-year dividend per share growth (CAGR)
12.79%
Bulls say / Bears say
Profitability is improving materially: in the second quarter of 2026, lease-adjusted EBITA rose to SEK 470m from SEK 349m, supported by higher occupancy and better operational efficiency in both business areas. (Attendo Q2 2026 report)
Attendo has scope to expand capacity into structurally growing care demand: its 2026 capital-markets presentation showed a pipeline of more than 1,200 beds and a new target of adjusted EPS above SEK 9 by 2028. (Attendo Capital Markets Day)
Shareholder returns provide a potential valuation catalyst: Attendo authorized a share buyback of up to SEK 275m between May 7 and August 19, 2026, alongside its stated focus on earnings distribution and balance-sheet discipline. (Attendo buyback announcement)
Revenue momentum remains modest: first-half 2026 net sales were SEK 9.408bn versus SEK 9.426bn a year earlier, while ended outsourcing and home-care contracts continued to weigh on Scandinavia. (Attendo Q2 2026 report)
Leadership transition adds execution risk: CEO Martin Tivéus is set to leave around the turn of 2026/2027, with Virpi Holmqvist appointed as successor. (Attendo)
The business remains lease-intensive, with SEK 13.459bn of lease liabilities at December 31, 2025; this raises the sensitivity of earnings and cash flow to occupancy, staffing efficiency and the execution of new capacity projects. (Attendo Annual and Sustainability Report 2025)
Data summarised monthly by Lightyear AI. Last updated on 10 Sept 2026.
Upcoming events
Funds containing Attendo AB
AllEURGBPUSD
Fund name | Fund size | Skr ATT weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.13% |
Xtrackers S&P 500 Swap£XSPX | £3.1B | 0.11% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.10% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.10% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.